2025年中国大动脉炎影像诊断与评估指南
该指南由专家小组提出临床问题,系统检索建库至2023年10月31日的证据,采用牛津大学循证医学中心分级系统评估证据质量,经德尔菲法共识形成17条推荐意见,涵盖影像方法选择与结果判读的总体原则、各模态优缺点及诊断评估选择、特殊人群与器官灌注的影像选择。
要点
- 指南共形成17条推荐,其中4条为总体原则,10条涉及不同影像模态的优缺点及诊断评估选择。
- 超声相关推荐3条,磁共振血管造影2条,CT血管造影2条,PET/CT 2条,数字减影血管造影1条。
- 最后3条推荐关注特殊人群的影像方法选择与器官灌注评估。
核心结论
- 这些推荐有助于规范临床医生在大动脉炎诊断与评估中影像方法的使用。
研究设计与样本
- 专家小组制定临床问题,系统检索建库至2023年10月31日发表的证据,采用牛津大学循证医学中心分级系统评估证据质量,通过德尔菲法共识形成推荐意见。
诊断标准与关键数值
- 共形成17条推荐意见:第1至4条为总体原则;第5至14条涵盖不同影像模态的优缺点及诊断评估中的影像选择,包括超声3条、磁共振血管造影2条、CT血管造影2条、PET/CT 2条、数字减影血管造影1条;第15至17条关注特殊人群的影像方法选择与器官灌注。
临床应用与阅片要点
- 指南旨在建立大动脉炎影像模态选择及结果判读的标准化方案,以辅助临床治疗决策。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Takayasu arteritis (TAK) presents as systemic vasculitis. Imaging is crucial for the diagnosis and evaluation of TAK, but the rational selection of imaging methods and interpretation of imaging results are major challenges in clinical practice, which can affect treatment decisions. This guideline aims to establish standardized protocols for selecting imaging modalities (as well as interpreting their findings) in TAK.
METHODS: Relevant clinical questions were formulated by an expert panel. Systematic reviews of evidence published from database establishment to 31 October 2023 were done. The grading system set by the Oxford University Evidence-Based Medicine Center was employed to assess the quality of evidence. Recommendations were developed through consensus using the Delphi method.
RESULTS: Seventeen recommendation statements were developed based on evidence summaries and consensus. The first four recommendations focused on overarching principles. Recommendations 5 to 14 covered the advantages and disadvantages of different imaging modalities, as well as the selection of imaging modalities in the diagnosis and evaluation of TAK, including ultrasound (three statements), magnetic resonance angiography (two), computed tomography angiography (two), positron emission tomography/computed tomography (two), and digital subtraction angiography (one). Recommendations 15 to 17 focused on the selection of imaging methods for special populations and organ perfusion.
CONCLUSION: These recommendations could help to standardize the use of imaging modalities by clinicians in the diagnosis and evaluation of TAK.
CLINICAL TRIAL NUMBER: Not applicable.
引用
- Liu Y, Ma L, Zhang Z, et al. 2025 Chinese guideline for the imaging diagnosis and evaluation of Takayasu arteritis. Adv Rheumatol. 2025. PMID: 40462247. doi:10.1186/s42358-025-00460-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。